EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Ankaferd Blood Stopper for Controlling Gastrointestinal Bleeding due to Distinct Benign Lesions Refractory to Conventional Antihemorrhagic Measures

Mevlut Kurt, Ibrahim Onal, Meral Akdogan, Murat Kekilli, Mehmet Arhan, Abdurrahim Sayilir, Erkin Oztas, Ibrahim Haznedaroglu

Canadian Journal of Gastroenterology · 2010 · 24 (6) · 380-384

DOI: 10.1155/2010/896819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Gastroenterology, 2010. Verfasst von Mevlut Kurt und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Turkiye Yuksek Ihtisas Teaching and Research Hospital, Kizilay Sok. No:2, 06100 Sihhiye, Ankara, Turkey. dr.mevlutkur…. Hauptthemen laut MEDLINE: Phytotherapy. Die Arbeit wurde bisher 43-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To assess the hemostatic efficacy of the Ankaferd Blood Stopper (ABS, Ankaferd Health Products Ltd, Turkey) hemostatic agent for controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures. METHODS: The records of all patients who underwent upper and lower endoscopy procedures at the Turkiye Yuksek Ihtisas Teaching and Research Hospital (Ankara, Turkey) between April 2008 and June 2009 were reviewed. Patients in whom ABS was used as a primary or adjuvant hemostatic agent were included in the study. Rates of bleeding control and postprocedural complications were documented. RESULTS: Hemostasis with no immediate complications was achieved in all patients within seconds of endoscopic application of ABS. CONCLUSIONS: ABS may have a role as a primary treatment or as an adjuvant to conventional modalities used to control gastrointestinal bleeding. Prospective controlled studies are needed to help establish its efficacy and, perhaps, offer a comparison with conventional hemostatic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhytotherapyGastrointestinal HemorrhageHemostaticsHumansPlant ExtractsRetrospective Studies

Substanzen

HemostaticsPlant Extractsankaferd blood stopper

Autor:innen und Institutionen

  • Department of Gastroenterology, Turkiye Yuksek Ihtisas Teaching and Research Hospital, Kizilay Sok. No:2, 06100 Sihhiye, Ankara, Turkey. dr.mevlutkurt@gmail.com

Zitieren

APA

Kurt, M., Onal, I., Akdogan, M., Kekilli, M., Arhan, M., Sayilir, A., Oztas, E., & Haznedaroglu, I. (2010). Ankaferd Blood Stopper for Controlling Gastrointestinal Bleeding due to Distinct Benign Lesions Refractory to Conventional Antihemorrhagic Measures. Canadian Journal of Gastroenterology, 24(6), 380-384. https://doi.org/10.1155/2010/896819

Vancouver

Kurt M, Onal I, Akdogan M, Kekilli M, Arhan M, Sayilir A, et al. Ankaferd Blood Stopper for Controlling Gastrointestinal Bleeding due to Distinct Benign Lesions Refractory to Conventional Antihemorrhagic Measures. Canadian Journal of Gastroenterology. 2010;24(6):380-384. doi:10.1155/2010/896819

BibTeX
@article{Kurt2010,
  author = {Kurt, Mevlut and Onal, Ibrahim and Akdogan, Meral and Kekilli, Murat and Arhan, Mehmet and Sayilir, Abdurrahim and Oztas, Erkin and Haznedaroglu, Ibrahim},
  title = {Ankaferd Blood Stopper for Controlling Gastrointestinal Bleeding due to Distinct Benign Lesions Refractory to Conventional Antihemorrhagic Measures},
  journal = {Canadian Journal of Gastroenterology},
  year = {2010},
  volume = {24},
  number = {6},
  pages = {380--384},
  doi = {10.1155/2010/896819}
}
Kostenlos starten →